Friday 15 March 2019

Submit your #abstract for #Keynote Speech, #Oral, #Poster Presentations,
Kindly submit the abstract and confirm your participation at Gynecology Congress 2019
Date and Venue: July 26-27 2019 #Melbourne, #AustraliaContact Email: #gynecology@healthcareevent.org


Updates In Gynecology

Use of beta-blockers during pregnancy has been associated with an increased risk for congenital heart disease in offspring, but this finding may be related to the indication for the drug (eg, maternal hypertension) rather than causal. In an analysis of pooled data from Nordic and United States cohorts of pregnant women with hypertension, beta-blocker use in the first trimester was not associated with an increased risk for major malformations overall or for cardiac malformations compared with no exposure (unfilled beta-blocker prescription). These data add to increasing evidence that, independent of confounders such as hypertension, it is unlikely that in utero exposure to beta-blockers significantly increases risk for malformations overall or for cardiac malformations. When oral antihypertensive therapy is indicated in early pregnancy, we prescribe labetalol or methyldopa for initial therapy.

No comments:

Post a Comment